Placentrex

Placentrex

Placentrex Gel is a topical medication used to treat wounds that are not healing or healing very slowly. It promotes wound healing with minimal scars
Product dosage: 20g
Package (num)Per tubePriceBuy
3$18.00$54.00 (0%)πŸ›’ Add to cart
4$17.50$72.00 $70.00 (3%)πŸ›’ Add to cart
5$17.00$90.00 $85.00 (6%)πŸ›’ Add to cart
6$16.50$108.00 $99.00 (8%)πŸ›’ Add to cart
7$16.14$126.00 $113.00 (10%)πŸ›’ Add to cart
8$15.75$144.00 $126.00 (12%)πŸ›’ Add to cart
9$15.33$162.00 $138.00 (15%)πŸ›’ Add to cart
10
$14.90 Best per tube
$180.00 $149.00 (17%)πŸ›’ Add to cart

Placentrex: Advanced Regenerative Therapy for Wound Healing

Placentrex is a biologically derived therapeutic agent, formulated from human placental extracts, designed to support and accelerate tissue repair and regeneration processes. As a prescription medication, it is indicated for the management of various conditions involving impaired wound healing, chronic ulcers, inflammation, and degenerative disorders. Its mechanism is rooted in modulating cellular activity, promoting angiogenesis, and enhancing collagen synthesis, making it a valuable option in medical settings where conventional treatments yield suboptimal results. Available in injectable and topical forms, Placentrex is utilized under medical supervision to address complex healing challenges across dermatological, surgical, and musculoskeletal contexts.

Features

  • Derived from human placental extract, processed under stringent aseptic conditions
  • Contains biologically active components including nucleotides, amino acids, enzymes, and vitamins
  • Available as injection (intramuscular, subcutaneous, or local infiltration) and topical gel/ointment formulations
  • Exhibits anti-inflammatory, angiogenic, and tissue regenerative properties
  • Manufactured in compliance with pharmacopeial standards and biological safety guidelines

Benefits

  • Accelerates wound epithelialization and granulation tissue formation in chronic non-healing wounds
  • Reduces inflammation and pain associated with degenerative and traumatic conditions
  • Enhances local microcirculation through promotion of angiogenesis
  • Supports functional recovery in nerve injuries and musculoskeletal disorders
  • Improves scar quality and reduces healing time in post-surgical and burn wounds
  • Provides a regenerative alternative in cases resistant to standard wound care protocols

Common use

Placentrex is commonly employed in the management of slow-healing wounds such as diabetic foot ulcers, venous stasis ulcers, and pressure sores. It is also used post-operatively to enhance recovery in surgical incisions, graft sites, and burn injuries. In orthopedics, it is administered for conditions like osteoarthritis, tendinitis, and peripheral neuropathy. Dermatological applications include radiation dermatitis, lichen sclerosus, and non-healing skin lesions. Its use is always determined by a healthcare provider based on clinical evaluation.

Dosage and direction

Dosage varies based on formulation, indication, and patient condition. For injectable forms: typically 2 mL administered intramuscularly, subcutaneously, or via local infiltration 2–3 times per week, with treatment duration ranging from 4 to 8 weeks. Topical formulations are applied thinly over affected areas 2–3 times daily. Always follow prescribing physician instructions. Do not self-administer injections; healthcare professional supervision is mandatory.

Precautions

Use under strict medical supervision. Avoid in areas with active infection or malignancy unless assessed by a physician. Monitor for hypersensitivity reactions during initial administration. Pregnancy and breastfeeding status should be disclosed before treatment. Do not use beyond expiration date or if packaging is compromised. Store away from light and excessive heat.

Contraindications

Hypersensitivity to any component of placental extract or similar biological products. Contraindicated in patients with known malignancies at application site. Not recommended in acute infectious conditions without concurrent antimicrobial therapy. Avoid in patients with severe systemic disorders unless risk-benefit is evaluated.

Possible side effect

Mild and transient side effects may include pain or burning at injection site, local erythema, or itching. Rarely, allergic reactions such as urticaria, rash, or fever may occur. Topical application can cause mild skin irritation in sensitive individuals. Discontinue use and seek medical attention if severe reactions develop.

Drug interaction

No well-documented significant drug interactions. However, inform your physician about all concurrent medications, especially immunosuppressants, anticoagulants, or topical corticosteroids. Theoretical interactions may exist with other biological therapies.

Missed dose

If a scheduled dose is missed, administer as soon as remembered unless it is almost time for the next dose. Do not double the dose. Maintain regular intervals as advised by the healthcare provider.

Overdose

No specific antidote is known. Symptoms of overdose are not well documented but may include exacerbated local or systemic reactions. In case of suspected overdose, seek immediate medical attention. Supportive and symptomatic management is recommended.

Storage

Store below 25Β°C, protected from light. Do not freeze. Keep out of reach of children. Discard unused portion after single use if opened or reconstituted.

Disclaimer

This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized dosage guidance. Use only as prescribed.

Reviews

Clinical studies and user reports indicate positive outcomes in wound healing and pain reduction, particularly in diabetic ulcers and osteoarthritis. Patients often report improved mobility and reduced dependency on analgesics. Medical professionals value its role in complex wound management. Individual results may vary.